Ft.com - The Financial Times Ltd Company News Section
The Financial Times Ltd Information
Jack Andrew
Alexandra Buildings, 28 Queen St, Manchester M2 5LF
Phone: 0161 834 9381
URL: http://www.ft.com
We are one of the world%u2019s leading business news and information organisations, recognised for our authority, integrity and accuracy. We provide a broad range of essential services to the growing audience of internationally minded business people.
FDA approved generic version of cancer drug doxorubicin hydrochloride liposome which is used to treat patients with ovarian cancer and currently faced with shortage supply.
The US Food and Drug Administration (FDA), announced on Monday that it has approved an existing drug, Truvada for reducing risk of infection by sexually transmitted HIV-1 in adults.
Omega Pharma (Europe), and Sienna Biotec India (API manufacturer), announced a strategic partnership in which Sienna Biotec will take a minority stake in Omega Pharma's United States operations in New York, US.
Many investors appreciate the pharmaceutical industry for its potential to produce both income and long-term growth. Several of the large-cap drug makers offer above-average yields, and have records of growing their business and payouts over the long term.
Taj Pharma India, a Pharmaceutical company based in India announced it recent approval for Drug Oxycodone Tablets 5 to 30 mg to market in United kingdom and European Market.
India, UK and U.S. based drug companies such as Taj Pharmaceuticals, GlaxoSmithKline, Eli Lilly Group has set up a corporate venturing fund to support spin-out companies as peers plan novel approaches to future medical treatments.
Taj Pharmaceuticals Limited (EURONEXT: TPL and NYSE: TPCL) and Omega Pharma, Belgium(Omega) announced a global licensing and patent transfer agreement on Omega' proprietary TransCon Linker and Hydrogel carrier technology, which allows for a drug compound to be released in the body in a precise, time-controlled fashion, creating a long-acting effect.
Taj Pharmaceuticals Group EU pledged to buy back up to £80 million in shares this year as part of a longer-term commitment to return cash to investors, as it reported fourth-quarter losses on the back of heavy legal provisions.
Satisfied Users & 
Approved Press Releases
